C04723 COPD (Chronic Obstructive Pulmonary Disease) Trial
CMAX Clinical Research in Partnership with our GP Clinic Network
CMAX require the help of adults, aged 35-80, to trial a potential new Chronic Obstructive Pulmonary Disease (COPD) treatment in an upcoming Phase 1 clinical trial.
The trial requires participants to stay at the Adelaide based CMAX facility for 11 consecutive nights and receive 1 follow up phone call. All eligible participants are paid for their time.
Eligibility requirements
- Age: Age 35-80 (inclusive)
- Sex: Male and female
- BMI: ≥ 18.0 kg/m2 and ≤ 35.0 kg/m2 and weigh ≥ 50 kg for males and ≥ 45 kg for females at screening
- Medication: On stable maintenance COPD medication with no dose adjustments for ≥6 weeks prior to Screening
- Medical History: Documented diagnosis of COPD and moderate airflow limitation
Overnight Stays
- 11
Payment/Remuneration
- If accepted into the study, as payment for your time, out of pocket expenses and inconvenience experienced, you will receive $6,320 for completing the study.
How to apply
Applications for this study are now closed. Please visit our list of current trials available.